EditorialPublished 29 Nov 2024
Precision Nanomedicine: Engineering Nanoscale Biomaterials for Targeted Delivery of CRISPR-Cas9 Gene Editing Tools
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The field of nanomedicine has witnessed transformative advancements with the integration of nanoscale biomaterials for precise therapeutic delivery. This review explores the emerging role of engineered nanomaterials in facilitating the targeted delivery of CRISPR-Cas9 gene-editing tools, a breakthrough technology in genome editing. By addressing key challenges such as off-target effects, immune responses, and delivery efficiency, nanoscale systems— including lipid nanoparticles, polymeric carriers, and hybrid nanocomposites—offer unprecedented control over cellular targeting and intracellular trafficking. These innovations hold the potential to revolutionize therapeutic interventions for genetic disorders, cancers, and infectious diseases, providing a pathway toward safer and more effective geneediting applications. Future directions focus on optimizing biocompatibility, improving in vivo targeting specificity, and advancing clinical translation of these precision nanomedicine strategies
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Arzlan Shu-Yan”